Current Essential Testing in Early Breast Cancer

Learn from a multidiscipinary panel of experts and enhance your knowledge on essential testing in early breast cancer with expert commentaries a podcast an online module downloadable slides and an on-demand webcast from a live webinar with a focus on BRCA testing and the role of PARP inhibition in early-stage breast cancer.

Share

Program Content

Activities

<i>BRCA</i> Testing in EBC and Adjuvant PARP Inhibition
Current Essential Testing in Early Breast Cancer: A Focus on BRCA Testing and Adjuvant PARP Inhibition
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: November 17, 2022

Expires: November 16, 2023

View Activity
Our Experiences With BRCA Testing and Adjuvant PARP Inhibition in EBC
Our Experiences With the Expanded Role of BRCA Testing and Adjuvant PARP Inhibition in Early Breast Cancer
Clinical Thought
Congratulations: You achieved a completion on 04/09/2022

Released: April 05, 2023

View Activity

Activities

<em>BRCA</em> Testing and Adjuvant PARP Inhibition
Essential Testing in Early Breast Cancer: A Focus on BRCA Testing and Adjuvant PARP Inhibition
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 14, 2022

Expires: November 13, 2023

View Activity

Activities

BRCA Testing and Adjuvant Therapy in EBC
BRCA Testing and Adjuvant Therapy in Early Breast Cancer: Experiences and Challenges
Podcast Episodes
Congratulations: You achieved a completion on 04/09/2022

Released: April 04, 2023

View Activity

Activities

BRCA and PARPi in EBC
Importance of BRCA Testing and the Role of PARP Inhibition in Early Breast Cancer
Slideset Download
Congratulations: You achieved a completion on 04/09/2022

Released: February 17, 2023

Expires: February 16, 2024

View Activity
BRCA Testing in EBC
BRCA Testing in Early Breast Cancer
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 28, 2023

Expires: February 27, 2024

View Activity
Initiation of Adjuvant Olaparib
Initiation of Adjuvant Olaparib and Recommended Monitoring
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: February 28, 2023

Expires: February 27, 2024

View Activity

Activities

BRCA Testing and PARPi in EBC
BRCA Testing and the Role of PARP Inhibition in Early Breast Cancer: A Multidisciplinary Roundtable
Text Module
Congratulations: You achieved a completion on 04/09/2022

Released: March 27, 2023

Expires: March 26, 2024

View Activity

Activities

Essential Testing in EBC
Current Essential Testing in Early Breast Cancer
Video
Congratulations: You achieved a completion on 04/09/2022

Released: March 31, 2023

Expires: March 30, 2024

View Activity

Faculty

cover img faculity

Allison Butts, PharmD, BCOP

Pharmacist Manager, Oncology
Clinical Pharmacist, Breast Oncology
Program Director, PGY2 Hematology/Oncology Pharmacy Residency
Assistant Adjunct Professor, UK College of Pharmacy
UK HealthCare
Lexington, Kentucky

cover img faculity

Charles E. Geyer, Jr., MD

Professor of Medicine
Division of Hematology/Medical Oncology
Department of Internal Medicine
University of Pittsburgh UPMC Hillman Cancer Center
Staff Attending
Breast Medical Oncology
UPMC Magee Womens Hospital
Pittsburgh, Pennsylvania

cover img faculity

Constance Albarracin, MD, PhD

Professor
Director, Breast Fellowship Program
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Banu Arun, MD

Professor, Breast Medical Oncology
Co-Director, Clinical Cancer Genetics 
Executive Director, Cancer Genetics
MD Anderson Cancer Networks
University of Texas MD Anderson Cancer Center
Houston, Texas

cover img faculity

Emilia Diego, MD, FACS

Division Chief
Division of Breast Surgery
University of Pittsburgh Medical Center
Co-Director
Division of Breast Surgery
UPMC Hillman Cancer Center Breast Program
Pittsburgh, Pennsylvania

cover img faculity

Marissa Marti-Smith, APRN, AGNP-C, AOCNP

Nurse Practitioner
Breast Oncology
Texas Oncology Baylor Sammons Cancer Center
Dallas, Texas

cover img faculity

Kristen Shannon, MS, CGC

Director
Mass General Cancer Center Genetics Program
Mass General Hospital Cancer Center
Boston, Massachusetts

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC in partnership with ProCE, LLC

Supporters

Supported by educational grants from

AstraZeneca

Merck Sharp & Dohme, LLC

Partners

ProCE

ProCE Banner